**Core Concept**
The **gold standard test** for diagnosing insulinoma, a type of pancreatic tumor that produces excess insulin, involves demonstrating **inappropriately high insulin levels** in the context of **hypoglycemia**. This test is crucial for differentiating insulinoma from other causes of hypoglycemia. The underlying principle is to assess the body's insulin secretion in relation to blood glucose levels.

**Why the Correct Answer is Right**
Although the specific correct answer option is not provided, the gold standard test for insulinoma typically involves a **72-hour fast test** under close supervision. This test monitors the patient's blood glucose, insulin, and other relevant hormone levels during a prolonged fast. The rationale is that in normal individuals, insulin levels decrease as blood glucose falls, whereas in patients with insulinoma, insulin secretion continues despite low blood glucose, leading to worsening hypoglycemia.

**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specifics, generally, any option that does not involve direct measurement of insulin in the context of hypoglycemia would be incorrect.
**Option B:** Similarly, an option that does not account for the dynamic nature of insulin secretion during hypoglycemia would not be accurate.
**Option D:** An option focusing solely on imaging or other indirect methods without assessing the functional impact on glucose and insulin levels would be inappropriate as a gold standard.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that the diagnosis of insulinoma relies on demonstrating **autonomous insulin secretion** despite low blood glucose levels. This is crucial for distinguishing it from other causes of hypoglycemia.

**Correct Answer:** D. 72-hour fast test.